These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Cayton RM; Webber B; Paterson JW; Clark TJ Br J Dis Chest; 1978 Jul; 72(3):222-4. PubMed ID: 359023 [TBL] [Abstract][Full Text] [Related]
3. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. Nelson HS; Spector SL; Whitsett TL; George RB; Dwek JH J Allergy Clin Immunol; 1983 Oct; 72(4):371-5. PubMed ID: 6352780 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two methods of administering bronchodilator aerosol to asthmatic patients. Choo-Kang YF; Grant IW Br Med J; 1975 Apr; 2(5963):119-20. PubMed ID: 1092420 [TBL] [Abstract][Full Text] [Related]
5. Salbutamol by pressure-packed aerosol and by intermittent positive pressure ventilation in chronic obstructive bronchitis. Berend N; Webster J; Marlin GE Br J Dis Chest; 1978 Apr; 72(2):122-4. PubMed ID: 348225 [TBL] [Abstract][Full Text] [Related]
7. Albuterol and isoproterenol in bronchial asthma. Efficacy and toxicity of drugs administered via intermittent positive pressure breathing. Light RW; Taylor RW; George RB Arch Intern Med; 1979 Jun; 139(6):639-43. PubMed ID: 375857 [TBL] [Abstract][Full Text] [Related]
8. Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Bloomfield P; Carmichael J; Petrie GR; Jewell NP; Crompton GK Br Med J; 1979 Mar; 1(6167):848-50. PubMed ID: 373852 [TBL] [Abstract][Full Text] [Related]
9. Comparison of salbutamol given by intermittent positive-pressure breathing and pressure-packed aerosol in chronic asthma. Anderson PB; Goude A; Peake MD Thorax; 1982 Aug; 37(8):612-6. PubMed ID: 6758179 [TBL] [Abstract][Full Text] [Related]
10. Effect of salbutamol with IPPB and physiotherapy for three days. Christensson P; Cimbritz H; Arborelius M; Jungquist G Scand J Respir Dis Suppl; 1977; 101():109-12. PubMed ID: 343233 [No Abstract] [Full Text] [Related]
11. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask. Parkes SN; Bersten AD Thorax; 1997 Feb; 52(2):171-5. PubMed ID: 9059480 [TBL] [Abstract][Full Text] [Related]
13. Salbutamol: comparison of bronchodilating effect of inhaled powder and aerosol in asthmatic subjects. Latimer KM; Roberts R; Dolovich J; Hargreave FE Can Med Assoc J; 1982 Nov; 127(9):857-9. PubMed ID: 7139504 [TBL] [Abstract][Full Text] [Related]
14. Severe acute asthma: a comparison of three methods of inhaling salbutamol. Webber BA; Collins JV; Branthwaite MA Br J Dis Chest; 1982 Jan; 76(1):69-74. PubMed ID: 7037036 [TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous injection of salbutamol in asthma. May CS; Paterson JW; Spiro SG; Johnson AJ Br J Clin Pharmacol; 1975 Dec; 2(6):495-501. PubMed ID: 1234013 [TBL] [Abstract][Full Text] [Related]
16. Salbutamol: tablets, inhalational powder, or nebuliser? Grimwood K; Johnson-Barrett JJ; Taylor B Br Med J (Clin Res Ed); 1981 Jan; 282(6258):105-6. PubMed ID: 6779890 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction. Pierce RJ; Allen CJ; Campbell AH Thorax; 1979 Feb; 34(1):45-50. PubMed ID: 375461 [TBL] [Abstract][Full Text] [Related]
18. The response of asthmatic children to the heated nebulization of salbutamol. Unter CE; Allan J; Dawson KP Aust Paediatr J; 1986 Aug; 22(3):211-3. PubMed ID: 3533025 [TBL] [Abstract][Full Text] [Related]
19. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma. Zainudin BM; Tolfree SE; Short M; Spiro SG Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642 [TBL] [Abstract][Full Text] [Related]
20. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Zainudin BM; Biddiscombe M; Tolfree SE; Short M; Spiro SG Thorax; 1990 Jun; 45(6):469-73. PubMed ID: 2392793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]